Intravitreal Dexamethasone Implant in the Treatment of Refractory Uveitic Macular Edema: A Case Report
Macular edema is the most common cause of vision loss in uveitis. It can respond to systemic or local steroids administered as either subtenon depot or intravitreal injection. Ozurdex (Allergan Pharmaceuticals) is a biodegradable dexamethasone intravitreal implant that contains 0.7mg of dexamethason...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2016-04-01
|
| Series: | Delhi Journal of Ophthalmology |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.7869/djo.185 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|